| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/06/2011 | EP2341141A2 Recombinant platelet collagen receptor glycoprotein VI , antibodies and their pharmaceutical use |
| 07/06/2011 | EP2341080A1 Humanized immunoglobulins and their production and use |
| 07/06/2011 | EP2341079A1 Immunoglobulin-binding proteins derived from Sac7d and uses thereof |
| 07/06/2011 | EP2341078A2 Monoclonal antibody against rhesus D |
| 07/06/2011 | EP2341077A1 Adenocarcinoma specific antibody SAM-6, and uses thereof |
| 07/06/2011 | EP2341076A2 Thymic stromal lymphopoietin (TSLP) antibodies and uses thereof |
| 07/06/2011 | EP2341075A1 Antibodies binding to the f protein of a respiratory syncytial virus (rsv) |
| 07/06/2011 | EP2341074A1 Antibodies binding to the f protein of a respiratory syncytial virus (rsv) |
| 07/06/2011 | EP2341071A1 Compostion and methods for increasing bone mineralization |
| 07/06/2011 | EP2341069A1 Polypeptides from non-typeable haemophilus influenzae |
| 07/06/2011 | EP2341067A1 Specific binding agents to hepatocyte growth factor |
| 07/06/2011 | EP2341064A1 Benzimidazole compounds and their use as chromatographic ligands |
| 07/06/2011 | EP2341060A1 Molecules with extended half-lives, compositions and uses thereof |
| 07/06/2011 | EP2340850A1 Inhibition of factor B, the alternative complement pathway and methods related thereto |
| 07/06/2011 | EP2340849A1 Anti-NGF antibodies for the treatment of various disorders |
| 07/06/2011 | EP2340845A2 Repeat sequences of the CA125 gene and their use for diagnostic and therapeutic interventions |
| 07/06/2011 | EP2340317A1 Determination of immunoglobulin encoding nucleid acid |
| 07/06/2011 | EP2340305A1 Cell lines and proteins with variant glycosylation pattern |
| 07/06/2011 | EP2340262A1 Formulations targeting igfbp7 for diagnosis and therapy of cancer |
| 07/06/2011 | EP2340039A1 Use of il-20 antagonists for treating rheumatoid arthritis and osteoporosis |
| 07/06/2011 | EP2340036A1 Induction of mucosal immune responses by mucosal delivery pentabody complex (mdpc) |
| 07/06/2011 | EP2340034A2 Radioprotectants targeting thrombospondin-1 and cd47 |
| 07/06/2011 | EP1891107B1 Compositions and methods for modulating immune responses |
| 07/06/2011 | EP1740206B1 Phep, an amino acid permease of staphylococcus aureus |
| 07/06/2011 | EP1730191B1 Immunoglobulin binding hosm |
| 07/06/2011 | EP1587834B1 Uses of il-23 mammalian cytokine; related reagents |
| 07/06/2011 | EP1537146B9 Antibodies binding to anionic phospholipids and aminophospholipids and their use in treating viral infections |
| 07/06/2011 | EP1326885B1 Non typeable Haemophilus influenzae BASB201 polypeptides and polynucleotides and uses thereof |
| 07/06/2011 | EP1317283B1 Tweak receptor agonists as anti-angiogenic agents |
| 07/06/2011 | CN1738900B Protein specific to pancreatic beta cells in islets of langerhans and applications thereof |
| 07/06/2011 | CN102119332A Immunomodulating compositions and methods of use thereof |
| 07/06/2011 | CN102119174A Compositions and methods of use for therapeutic antibodies |
| 07/06/2011 | CN102119173A Gelsolin binding agent compositions and uses of same |
| 07/06/2011 | CN102119171A CDCA1 epitope peptides and vaccines containing the same |
| 07/06/2011 | CN102115732A Anti-rat ATF3 (activating transcription factor 3) monoclonal antibody secreted by hybridoma cell strain WXR |
| 07/06/2011 | CN102115492A Vascular endothelial growth factor receptor partial polypeptide and application thereof |
| 07/06/2011 | CN101538327B Anthropogenic H5N1-resisting hemagglutinin protein broad-spectrum neutralising antibody and application thereof |
| 07/06/2011 | CN101074263B Recombinant proteinA monoclonal antibody, its production and use |
| 07/06/2011 | CN101050464B Method for preparing A gene of recombined protein, and expressed products and application |
| 07/05/2011 | USRE42524 Colloidal metal compositions and methods |
| 07/05/2011 | US7973151 Nucleic acid encoding modified human thymic stromal lymphopoietin |
| 07/05/2011 | US7973150 Reducing the immunogenicity of fusion proteins |
| 07/05/2011 | US7973143 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 07/05/2011 | US7973142 Antibodies that bind human protein tyrosine phosphatase beta (HPTPβ) |
| 07/05/2011 | US7973140 Blood vessel specific immunoglobulins for use in prevention and treatment of cell proliferative disorders |
| 07/05/2011 | US7973139 Antibodies against nogo receptor |
| 07/05/2011 | US7973136 Hodgkin's lymphoma surface protein specific immunoglobulin for use in treatment and prevention of cell proliferative disorders; immunotherapy |
| 07/05/2011 | US7973134 Reagents for the detection of protein phosphorylation in anaplastic large cell lymphoma signaling pathways |
| 07/05/2011 | US7973130 Mammalian tumor susceptibility genes and their uses |
| 07/05/2011 | US7973019 Transferrin/transferrin receptor-mediated siRNA delivery |
| 07/05/2011 | US7972848 Isolation and identification of cross-reactive T cells |
| 07/05/2011 | US7972846 Cadherin-11 antagonists and methods for the treatment of inflammatory joint disorders |
| 07/05/2011 | US7972845 Human antibodies against Pseudomonas aeruginosa LPS derived from transgenic xenomouse |
| 07/05/2011 | US7972812 DNA encoding a soluble fragment of TRAIL polypeptide |
| 07/05/2011 | US7972811 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries |
| 07/05/2011 | US7972809 Methylotrophic yeast producing mammalian type sugar chain |
| 07/05/2011 | US7972797 Compositions and methods for the diagnosis and treatment of immune disorders |
| 07/05/2011 | US7972600 IGF-IR antagonists as adjuvants for treatment of prostate cancer |
| 07/05/2011 | US7972597 Methods of reducing chemotaxis using antibodies against monocyte chemotactic proteins |
| 07/05/2011 | US7972596 Antibodies against vascular endothelial growth factor receptor-1 |
| 07/05/2011 | CA2521382C Method for the construction of randomized gene sequence libraries in cells |
| 07/05/2011 | CA2488630C Immunoadhesin comprising a glycoprotein vi domain |
| 07/05/2011 | CA2466629C Expression control using variable intergenic sequences |
| 07/05/2011 | CA2401491C Ccr4-binding antibody and diagnostic and therapeutic uses thereof |
| 07/05/2011 | CA2380066C Antitumor antibodies, proteins, and uses thereof |
| 07/05/2011 | CA2288994C Polyalkylene oxide-modified single chain polypeptides |
| 07/05/2011 | CA2220133C Recombinant vesiculoviruses and their uses |
| 07/05/2011 | CA2204636C Diagnostic method and kit for determining kell blood group genotype |
| 06/30/2011 | WO2011079308A2 Compositions comprising tnf-alpha and il-6 antagonists and methods of use thereof |
| 06/30/2011 | WO2011079283A1 Anti-epcam antibodies that induce apoptosis of cancer cells and methods using same |
| 06/30/2011 | WO2011079257A2 Human antibodies to human angiopoietin-like protein 4 |
| 06/30/2011 | WO2011079185A1 Anti-bv8 antibodies and uses thereof |
| 06/30/2011 | WO2011078990A1 Hydrogels comprising hyaluronan and at least one t cell induction agent |
| 06/30/2011 | WO2011078456A1 Human antibodies specifically binding to the hepatitis b virus surface antigen |
| 06/30/2011 | WO2011078384A1 Method for measuring human insulin and measurement reagent |
| 06/30/2011 | WO2011078332A1 Polypeptide modification method for purifying polypeptide multimers |
| 06/30/2011 | WO2011078308A1 GENE Dro1 CONTROLLING DEEP-ROOTED CHARACTERISTICS OF PLANT AND UTILIZATION OF SAME |
| 06/30/2011 | WO2011077395A1 IMMUNOGLOBULIN-BINDING PROTEINS DERIVED FROM Sac7d AND USES THEREOF |
| 06/30/2011 | WO2011077143A1 Transformation of commensal neisseria |
| 06/30/2011 | WO2011077133A2 Method of treatment and screening method |
| 06/30/2011 | WO2011077102A1 Recombinant factor h and variants and conjugates thereof |
| 06/30/2011 | WO2011076922A1 Anti-flt3 antibodies and methods of using the same |
| 06/30/2011 | WO2011076883A1 Binding members for human cytomegalovirus |
| 06/30/2011 | WO2011076781A1 Tetravalent cd47-antibody constant region fusion protein for use in therapy |
| 06/30/2011 | WO2011076684A1 Sequence dependent aggregation |
| 06/30/2011 | WO2011076683A1 Anti-her3 antibodies and uses thereof |
| 06/30/2011 | WO2011075861A1 Method for decreasing immunogenicity |
| 06/30/2011 | WO2011075789A1 Antibodies to non-functional oligomeric p2x7 receptors |
| 06/30/2011 | WO2011075786A1 Immuno-conjugates and methods for producing them 2 |
| 06/30/2011 | WO2011054997A3 Monoclonal antibody that recognises the gapdh protein of candida famata |
| 06/30/2011 | WO2011051327A3 Small antibody-like single chain proteins |
| 06/30/2011 | WO2011041319A3 Specific binding proteins and uses thereof |
| 06/30/2011 | WO2011038933A3 Anti-hsv antibody |
| 06/30/2011 | WO2010126670A9 Compositions and methods for screening and using compounds antagonizing spore-surface interactions |
| 06/30/2011 | US20110162114 Selection method ii |
| 06/30/2011 | US20110162113 Antibodies |
| 06/30/2011 | US20110160445 Heparin-Binding Growth Factor (HBGF) Polypeptides |
| 06/30/2011 | US20110160440 Cab Molecules |
| 06/30/2011 | US20110160439 Design of specific ligands to sortilin |
| 06/30/2011 | US20110160438 Il-17 receptor like molecules and uses thereof |